11/14/2012 Researchers at the National Cancer Institute have discovered a new way in which PARP inhibitors block cancer cell growth. They also discovered that three experimental PARP inhibitors vary widely in their ability to kill cancer cells. PARP inhibitors are a class of drugs that have shown promising results against ovarian cancer in women with … Continued
A study conducted by the Centers for Disease Control and Prevention showed that women were not aware of the non-gynecologic symptoms of gynecologic cancers, such as abdominal or back pain. Therefore, women did not recognize the urgency of seeking care for these symptoms. The study concludes that “[r]aising awareness of symptoms that can indicate gynaecologic … Continued
11/09/2012 A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, suggests that women who have surgery for ovarian cancer at high-volume hospitals have superior outcomes than similar patients at low-volume hospitals. The improved survival rate is not dependent on … Continued
This morning the Ovarian Cancer National Alliance sent a letter to President Obama congratulating him on his re-election and outlining some of our policy priorities for his second term. Click here to view a pdf of the letter, or read it below. November 7, 2012 President Barack Obama 1600 Pennsylvania Avenue, NW Washington, DC 20500 … Continued
11/05/2012 In an article published in Cancer Prevention Research, a group of researchers in Australia examined the relationship between lifetime exposure to solar ultraviolet radiation (UVR) and ovarian cancer. The study concluded that women in the highest third of average daily ambient UVR exposure over their lifetime were at significantly lower risk of all epithelial … Continued
11/02/2012 In a study published in the journal Cancer Epidemiology, Australian researchers examined the relationship between tea drinking and the risk of ovarian cancer among southern Chinese women. The study, which included 500 women with serous ovarian cancer and 500 controls, found that regular tea consumption is associated with a reduced risk of ovarian cancer … Continued
As an avid outdoorswoman and an ovarian cancer survivor, Sean Patrick saw connections between both sides of her life. She once said: “The skills women learn in climbing—problem solving, risk taking and confidence in their decision making—will enable them to climb all the mountains in their lives.” In 2001, while recovering from her seventh ovarian … Continued
10/29/2012 Research published in Cancer Epidemiology, Biomarkers, and Prevention shows that type II diabetes mellitus was not associated with risk of epithelial ovarian cancer. The risk ration was higher for type II diabetes with insulin use than for type II diabetes without insulin use. Diabetes seemed to be more strongly associated with noserous than serous … Continued
The National Comprehensive Cancer Network (NCCN) released new guidelines on palliative care for cancer patients. “The guidelines outline procedures for screening, assessment, palliative care interventions, reassessment, and after-death care.”
Michelle Andrews of Kaiser Health News talks about health insurance companies’ coverage of chemotherapy. Watch the clip here.
A new study indicates that the stiffness of an ovarian cancer cell can indicate whether or not it is likely to be metastatic: the more stiff the cell is, the more likely it is to be malignant. The abstract is here An article on the study is here
Dr. Ruprecht Wiedemeyer is a 2012 Liz Tilberis Grantee. In this interview with OCRF's Sarah DeFeo, Dr. Wiedemeyer discusses his research and what it means to receive a grant from OCRF.
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
